Free Trial

Apogee Therapeutics (APGE) SEC Filings & 10K Form

Apogee Therapeutics logo
$40.36 +0.18 (+0.45%)
Closing price 04:00 PM Eastern
Extended Trading
$40.43 +0.07 (+0.17%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Apogee Therapeutics SEC Filings

DateFilerForm TypeView
05/12/2025
9:44 AM
Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/12/2025
5:30 AM
Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
5:15 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
3:15 PM
Apogee Therapeutics (Filer)
Form DEF 14A
04/04/2025
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
5:30 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
12:46 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
6:06 AM
Apogee Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:12 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
5:30 AM
Apogee Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM
Apogee Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G
02/07/2025
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
1:02 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:05 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
7:00 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
11:23 AM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2025
7:00 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
5:00 AM
Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:02 PM
Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:02 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:59 PM
Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
6:30 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
10:12 AM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
5:17 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:46 PM
Apogee Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
10:16 AM
Apogee Therapeutics (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
11/14/2024
9:18 AM
Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/12/2024
6:15 AM
Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
6:05 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
10:39 AM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

11/04/2024
6:59 PM
ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by)
Apogee Therapeutics (Subject)
Form SC 13G/A
10/24/2024
7:10 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
Apogee Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/04/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
9:05 AM
Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
10/02/2024
3:20 PM
Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
1:34 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
7:02 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
7:03 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
12:35 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
7:05 PM
Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:29 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:25 PM
Apogee Therapeutics (Filer)
Form S-3ASR
08/12/2024
6:00 AM
Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
5:35 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:05 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
7:05 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
12:18 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2024
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
12:39 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
12:13 PM
Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
7:12 PM
Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:00 PM
Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:01 PM
Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:02 PM
Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:03 PM
Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:04 PM
Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:05 PM
Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:05 PM
Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2024
7:07 PM
Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:35 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
6:36 AM
Apogee Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APGE) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners